T. Unger, The role of the renin-angiotensin system in the development of cardiovascular disease, The American Journal of Cardiology, vol.89, issue.2, pp.3-9, 2002.
DOI : 10.1016/S0002-9149(01)02321-9

P. Sleight, Angiotensin II and trials of cardiovascular outcomes11Reprints are not available., The American Journal of Cardiology, vol.89, issue.2, pp.11-17, 2002.
DOI : 10.1016/S0002-9149(01)02322-0

M. Flather, S. Yusuf, and L. Kober, Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients, The Lancet, vol.355, issue.9215, pp.1575-81, 2000.
DOI : 10.1016/S0140-6736(00)02212-1

F. Turnbull, B. Neal, and M. Pfeffer, Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system, J Hypertens, vol.25, issue.5, pp.951-959, 2007.

S. Litwin, S. Katz, and E. Weinberg, Serial Echocardiographic-Doppler Assessment of Left Ventricular Geometry and Function in Rats With Pressure-Overload Hypertrophy : Chronic Angiotensin-Converting Enzyme Inhibition Attenuates the Transition to Heart Failure, Circulation, vol.91, issue.10, pp.2642-54, 1995.
DOI : 10.1161/01.CIR.91.10.2642

W. Brooks, O. Bing, and K. Robinson, Effect of Angiotensin-Converting Enzyme Inhibition on Myocardial Fibrosis and Function in Hypertrophied and Failing Myocardium From the Spontaneously Hypertensive Rat, Circulation, vol.96, issue.11, pp.4002-4012, 1997.
DOI : 10.1161/01.CIR.96.11.4002

Y. Sakata, K. Yamamoto, and T. Mano, Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction, Cardiovascular Research, vol.57, issue.3, pp.757-65, 2003.
DOI : 10.1016/S0008-6363(02)00722-8

L. Kober, C. Torp-pedersen, and J. Carlsen, A Clinical Trial of the Angiotensin-Converting???Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction, New England Journal of Medicine, vol.333, issue.25, pp.1670-1676, 1995.
DOI : 10.1056/NEJM199512213332503

X. Wehrens and A. Marks, Novel therapeutic approaches for heart failure by normalizing calcium cycling, Nature Reviews Drug Discovery, vol.87, issue.7, pp.565-73, 2004.
DOI : 10.1046/j.1540-8167.2003.03050.x

D. Kaye, M. Hoshijima, and K. Chien, Cycling, Annual Review of Medicine, vol.59, issue.1, pp.13-28, 2008.
DOI : 10.1146/annurev.med.59.052407.103237

D. Bers, Altered Cardiac Myocyte Ca Regulation In Heart Failure, Physiology, vol.21, issue.6, pp.380-387, 2006.
DOI : 10.1152/physiol.00019.2006

B. Jugdutt, Preventing Adverse Remodeling and Rupture During Healing After Myocardial Infarction in Mice and Humans, Circulation, vol.122, issue.2, pp.103-108, 2010.
DOI : 10.1161/CIRCULATIONAHA.110.969410

B. Ren, Q. Shao, and P. Ganguly, Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction, Canadian Journal of Physiology and Pharmacology, vol.82, issue.12, pp.1118-1145, 2004.
DOI : 10.1139/y04-115

X. Guo, D. Chapman, and N. Dhalla, Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan, Molecular and Cellular Biochemistry, vol.254, issue.1/2, pp.163-72, 2003.
DOI : 10.1023/A:1027321130997

Q. Shao, B. Ren, and A. Zarain-herzberg, Captopril Treatment Improves the Sarcoplasmic Reticular Ca2+Transport in Heart Failure Due to Myocardial Infarction, Journal of Molecular and Cellular Cardiology, vol.31, issue.9, pp.1663-72, 1999.
DOI : 10.1006/jmcc.1999.1000

A. Coca, Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage, Expert Review of Cardiovascular Therapy, vol.5, issue.2, pp.147-59, 2007.
DOI : 10.1586/14779072.5.2.147

M. Bevilacqua, T. Vago, and A. Rogolino, Affinity of Angiotensin I-Converting Enzyme (ACE) Inhibitors For N- and C-Binding Sites of Human ACE Is Different in Heart, Lung, Arteries, and Veins, Journal of Cardiovascular Pharmacology, vol.28, issue.4, pp.494-503, 1996.
DOI : 10.1097/00005344-199610000-00003

K. Acharya, E. Sturrock, J. Riordan, and M. Ehlers, Ace revisited: A new target for structure-based drug design, Nature Reviews Drug Discovery, vol.85, issue.11, pp.891-902, 2003.
DOI : 10.1016/S1359-6446(02)02233-X

R. Razzetti and D. Acerbi, Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor, The American Journal of Cardiology, vol.75, issue.16, pp.7-12, 1995.
DOI : 10.1016/S0002-9149(99)80508-6

O. Tarnavski, J. Mcmullen, and M. Schinke, Mouse Cardiac Surgery: Comprehensive Techniques for the Generation of Mouse Models of Human Diseases and Their Application for Genomic Studies, Physiological Genomics, vol.16, issue.3, pp.349-60, 2004.
DOI : 10.1152/physiolgenomics.00041.2003

S. Masson, M. Masseroli, and F. Fiordaliso, Effects of a DA2/??2 Agonist and a ??1-Blocker in Combination with an ACE Inhibitor on Adrenergic Activity and Left Ventricular Remodeling in an Experimental Model of Left Ventricular Dysfunction After Coronary Artery Occlusion, Journal of Cardiovascular Pharmacology, vol.34, issue.3, pp.321-327, 1999.
DOI : 10.1097/00005344-199909000-00001

A. Finsen, G. Christensen, and I. Sjaastad, Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse, Journal of Applied Physiology, vol.98, issue.2, pp.680-689, 2005.
DOI : 10.1152/japplphysiol.00924.2004

S. Joho, S. Ishizaka, and R. Sievers, Left ventricular pressure-volume relationship in conscious mice, AJP: Heart and Circulatory Physiology, vol.292, issue.1, pp.369-7715, 2006.
DOI : 10.1152/ajpheart.00704.2006

J. Thireau, F. Aimond, and D. Poisson, New Insights into Sexual Dimorphism during Progression of Heart Failure and Rhythm Disorders, Endocrinology, vol.151, issue.4, pp.1837-1882, 2010.
DOI : 10.1210/en.2009-1184

J. Fauconnier, J. Thireau, and S. Reiken, Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy, Proceedings of the National Academy of Sciences, vol.107, issue.4, pp.1559-64, 2010.
DOI : 10.1073/pnas.0908540107

T. Flagg, O. Cazorla, and M. Remedi, Ca2+-Independent Alterations in Diastolic Sarcomere Length and Relaxation Kinetics in a Mouse Model of Lipotoxic Diabetic Cardiomyopathy, Circulation Research, vol.104, issue.1, pp.95-103, 2009.
DOI : 10.1161/CIRCRESAHA.108.186809

K. Quang, P. Naud, and X. Qi, Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice, Cardiovascular Research, vol.91, issue.3, pp.420-428, 2011.
DOI : 10.1093/cvr/cvr082

S. Minamisawa, M. Hoshijima, and G. Chu, Chronic Phospholamban???Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated Cardiomyopathy, Cell, vol.99, issue.3, pp.313-335, 1999.
DOI : 10.1016/S0092-8674(00)81662-1

J. Schmitt, M. Kamisago, and M. Asahi, Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban, Science, vol.299, issue.5611, pp.1410-1413, 2003.
DOI : 10.1126/science.1081578

O. Cazorla, A. Lucas, and F. Poirier, The cAMP binding protein Epac regulates cardiac myofilament function, Proceedings of the National Academy of Sciences, vol.106, issue.33, pp.14144-14153, 2009.
DOI : 10.1073/pnas.0812536106

N. Hamdani, V. Kooij, and S. Van-dijk, Sarcomeric dysfunction in heart failure, Cardiovascular Research, vol.77, issue.4, pp.649-58, 2008.
DOI : 10.1093/cvr/cvm079

R. Belin, M. Sumandea, and E. Allen, Augmented Protein Kinase C-??-Induced Myofilament Protein Phosphorylation Contributes to Myofilament Dysfunction in Experimental Congestive Heart Failure, Circulation Research, vol.101, issue.2, pp.195-204, 2007.
DOI : 10.1161/CIRCRESAHA.107.148288

I. Hobai, O. Rourke, and B. , Decreased Sarcoplasmic Reticulum Calcium Content Is Responsible for Defective Excitation-Contraction Coupling in Canine Heart Failure, Circulation, vol.103, issue.11, pp.1577-84, 2001.
DOI : 10.1161/01.CIR.103.11.1577

V. Piacentino, C. Weber, and X. Chen, Cellular Basis of Abnormal Calcium Transients of Failing Human Ventricular Myocytes, Circulation Research, vol.92, issue.6, pp.651-659, 2003.
DOI : 10.1161/01.RES.0000062469.83985.9B

R. Latini, A. Maggioni, and M. Flather, ACE Inhibitor Use in Patients With Myocardial Infarction : Summary of Evidence From Clinical Trials, Circulation, vol.92, issue.10, pp.3132-3139, 1995.
DOI : 10.1161/01.CIR.92.10.3132

E. Bartha, G. Kiss, and E. Kalman, Effect of L-2286, a Poly(ADP-ribose)polymerase Inhibitor and Enalapril on Myocardial Remodeling and Heart Failure, Journal of Cardiovascular Pharmacology, vol.52, issue.3, pp.253-61, 2008.
DOI : 10.1097/FJC.0b013e3181855cef

K. Chiba, S. Moriyama, and Y. Ishigai, Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery, British Journal of Pharmacology, vol.68, issue.Suppl I, pp.837-879, 1994.
DOI : 10.1111/j.1476-5381.1994.tb13155.x

M. Bohm, M. Castellano, and E. Agabiti-rosei, Dose-Dependent Dissociation of ACE-Inhibitor Effects on Blood Pressure, Cardiac Hypertrophy, and ??-Adrenergic Signal Transduction, Circulation, vol.92, issue.10, pp.3006-3019, 1995.
DOI : 10.1161/01.CIR.92.10.3006

Y. Takeishi, A. Bhagwat, and N. Ball, Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure, Am J Physiol, vol.276, issue.1 2, pp.53-62, 1999.

S. Boateng, R. Naqvi, and M. Koban, Low-dose ramipril treatment improves relaxation and calcium cycling after established cardiac hypertrophy, Am J Physiol Heart Circ Physiol, vol.280, issue.3, pp.1029-1067, 2001.

V. Kadambi, S. Ponniah, and J. Harrer, Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice., Journal of Clinical Investigation, vol.97, issue.2, pp.533-542, 1996.
DOI : 10.1172/JCI118446

F. Yamaguchi, A. Sanbe, and S. Takeo, Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction, British Journal of Pharmacology, vol.31, issue.suppl I, pp.326-360, 1998.
DOI : 10.1038/sj.bjp.0701592

S. Reiken, A. Lacampagne, and H. Zhou, PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle, The Journal of Cell Biology, vol.87, issue.6, pp.919-947, 2003.
DOI : 10.1161/01.CIR.96.8.2683

G. Hasenfuss, W. Schillinger, and S. Lehnart, Relationship Between Na+-Ca2+??Exchanger Protein Levels and Diastolic Function of Failing Human Myocardium, Circulation, vol.99, issue.5, pp.641-649, 1999.
DOI : 10.1161/01.CIR.99.5.641

R. Studer, H. Reinecke, and J. Bilger, Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure, Circulation Research, vol.75, issue.3, pp.443-53, 1994.
DOI : 10.1161/01.RES.75.3.443

M. Flesch, R. Schwinger, and F. Schiffer, Evidence for Functional Relevance of an Enhanced Expression of the Na+-Ca2+ Exchanger in Failing Human Myocardium, Circulation, vol.94, issue.5, pp.992-1002, 1996.
DOI : 10.1161/01.CIR.94.5.992

A. Gomez, B. Schwaller, and H. Porzig, Increased Exchange Current but Normal Ca2+ Transport via Na+-Ca2+ Exchange During Cardiac Hypertrophy After Myocardial Infarction, Circulation Research, vol.91, issue.4
DOI : 10.1161/01.RES.0000031384.55006.DB

J. Wasserstrom, E. Holt, and I. Sjaastad, Altered E-C coupling in rat ventricular myocytes from failing hearts 6 wk after MI, Am J Physiol Heart Circ Physiol, vol.279, issue.2, pp.798-807, 2000.

I. Dixon, T. Hata, and N. Dhalla, Sarcolemmal Na(+)-K(+)-ATPase activity in congestive heart failure due to myocardial infarction, Am J Physiol, vol.262, issue.3, pp.664-71, 1992.

N. Makino, T. Hata, and M. Sugano, Regression of Hypertrophy After Myocardial Infarction is Produced by the Chronic Blockade of Angiotensin Type 1 Receptor in Rats, Journal of Molecular and Cellular Cardiology, vol.28, issue.3, pp.507-524, 1996.
DOI : 10.1006/jmcc.1996.0047

R. Sethi, K. Dhalla, and P. Ganguly, Beneficial effects of propionyl ?-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction, Cardiovascular Research, vol.42, issue.3, pp.607-622, 1999.
DOI : 10.1016/S0008-6363(99)00089-9

R. Belin, M. Sumandea, and T. Kobayashi, Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure, AJP: Heart and Circulatory Physiology, vol.291, issue.5, pp.2344-53, 2006.
DOI : 10.1152/ajpheart.00541.2006

J. Wang, X. Liu, and E. Sentex, Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction, American Journal of Physiology - Heart and Circulatory Physiology, vol.284, issue.6, pp.2277-87, 2003.
DOI : 10.1152/ajpheart.00142.2002

G. Simonis, M. Dahlem, and T. Hohlfeld, A novel activation process of protein kinase C in the remote, non-ischemic area of an infarcted heart is mediated by angiotensin-AT1 receptors, Journal of Molecular and Cellular Cardiology, vol.35, issue.11, pp.1349-58, 2003.
DOI : 10.1016/S0022-2828(03)00250-5

G. Simonis, M. Braun, and M. Kirrstetter, Mechanisms of Myocardial Remodeling: Ramiprilat Blocks the Expressional Upregulation of Protein Kinase C-?? in the Surviving Myocardium Early After Infarction, Journal of Cardiovascular Pharmacology, vol.41, issue.5, pp.780-787, 2003.
DOI : 10.1097/00005344-200305000-00016

R. Belin, M. Sumandea, and G. Sievert, Interventricular differences in myofilament function in experimental congestive heart failure, Pfl??gers Archiv - European Journal of Physiology, vol.291, issue.4, pp.795-809, 2011.
DOI : 10.1007/s00424-011-1024-4
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246750

N. Jideama, T. Noland, J. Raynor, and R. , Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties, J Biol Chem, vol.271, issue.38, pp.23277-83, 1996.

T. Noland, J. Raynor, R. Kuo, and J. , Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites, J Biol Chem, vol.264, issue.34, pp.20778-85, 1989.